What is this medicine used for?
FDA-approved uses
- Schizophrenia — Adults and pediatric patients aged 13 years and older. Separate adult and pediatric titration; target and organ-function limits apply.Rexulti oral tablets.
- Adjunctive treatment of major depressive disorder — Adults. Added to antidepressant treatment; not pediatric or stand-alone depression approval.Rexulti oral tablets.
- Agitation associated with dementia due to Alzheimer’s disease — Adults with the specified Alzheimer-related agitation. Scheduled treatment, not as needed. This does not remove the boxed mortality warning or approve all dementia-related psychosisPsychosisPsychosis describes symptoms that affect a person’s ability to tell what is real. These can include hallucinations, delusions and disorganized thinking or speech.Psychosis can occur with different mental or physical health conditions, some medicines or substance use. It does not automatically mean schizophrenia. New symptoms need prompt professional assessment..Rexulti oral tablets.
What should I expect?
Benefit is assessed during regular treatment and gradual dose changes over several weeks. For depression it is added to an antidepressant; for Alzheimer-related agitation it is scheduled treatment rather than an occasional rescue dose.
Track the symptoms being treated alongside sleepiness, restlessness, appetite, weight and functioning. Contact the prescribing team if benefit remains unclear, side effects interfere, or new compulsive urges appear.
How do I take it safely?
Take once daily with or without food. Follow the schedule for the specific diagnosis and age; Alzheimer-related agitation treatment is not prescribed as needed.
Monitor weight, glucose, blood fats, blood pressure, unusual movements, restlessness and falls. Ask caregivers to watch for new compulsive urges and changes in swallowing or alertness.
Kidney or liver impairment can lower the maximum dose. Several enzyme-blocking or enzyme-inducing medicines need adjustments; the rules differ for depression add-on treatment, so have the actual combination reviewed.
Tell the clinician about heart disease, seizures, diabetes risk, low white blood cells, dehydration, swallowing difficulty or previous compulsive behaviors. Avoid alcohol and unreviewed sedatives; take care with driving, heat and standing up quickly.
For a missed dose, take it when remembered unless the next is near, then skip; never double. Plan stopping or switching with the prescriber and report new compulsive behavior promptly.
Discuss pregnancy and breastfeeding. Late-pregnancy antipsychotic exposure can affect a newborn’s movement, feeding or breathing. Older adults require particular attention to falls, stroke and mortality risk.
Do not use after a known allergy to brexpiprazole or product ingredients. A history of low white blood cells may require blood-count monitoring.
What side effects should I know about?
- Weight gain, sleepiness, akathisiaAkathisiaAkathisia is distressing inner restlessness with a strong urge to move, sometimes caused by medication. It may lead to pacing, rocking or difficulty sitting still.Anxiety involves fear or worry; agitation is a broader state of distress or restlessness. These can overlap with akathisia, but the compelling urge to move is an important clue. Tell your prescriber promptly about new or worsening restlessness so the cause can be assessed. or other movement symptoms depending on population.
- Dizziness can occur; older adults require attention to falls.
Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.
Looking for more detailed information?
The official medicine information lists more side effects, safety advice and product instructions.
- View FDA Prescribing Information (PDF) (opens in a new tab)Rexulti: current sponsor prescribing information
Which warning signs need help?
- FDA boxed warningsFDA boxed warningAn FDA boxed warning is a prominently displayed warning in US prescribing information about especially serious risks, which may include death or serious injury. It is sometimes called a black-box warning.It highlights information that needs particular attention when deciding whether and how to use a medicine. A boxed warning does not mean the medicine is banned or that everyone will experience the harm. Read the medicine-specific warning and discuss it with your prescriber. address increased mortality in older adults with dementia-related psychosisPsychosisPsychosis describes symptoms that affect a person’s ability to tell what is real. These can include hallucinations, delusions and disorganized thinking or speech.Psychosis can occur with different mental or physical health conditions, some medicines or substance use. It does not automatically mean schizophrenia. New symptoms need prompt professional assessment. and suicidal thoughts and behaviors in pediatric and young adult antidepressant-treated patients. Rexulti is not approved for dementia-related psychosisPsychosisPsychosis describes symptoms that affect a person’s ability to tell what is real. These can include hallucinations, delusions and disorganized thinking or speech.Psychosis can occur with different mental or physical health conditions, some medicines or substance use. It does not automatically mean schizophrenia. New symptoms need prompt professional assessment. without agitation associated with Alzheimer’s dementia. Its specific agitation approval does not remove the mortality risk. Pediatric depression effectiveness is not established.
- High fever with severe muscle stiffness, confusion or unstable pulse can be neuroleptic malignant syndrome; get emergency care.
- Get emergency help for sudden weakness on one side or trouble speaking, which can be stroke symptoms.
- Report new involuntary movements promptly because they can persist. Fainting, falls, fever with infection symptoms, swallowing difficulty or severe restlessness also needs assessment.
- Marked thirst, frequent urination, severe weakness or confusion may signal high blood sugar; seek prompt assessment.
- New compulsive gambling, shopping, eating or sexual urges need prompt prescriber contact.
- New suicidal thoughts or a severe mood or behavior change needs immediate clinical contact; get emergency help if someone cannot stay safe.
- Get emergency help for trouble breathing, swelling of the tongue or throat, collapse, a seizure or inability to wake. Suspected overdose needs immediate poison-center or emergency advice; do not wait for symptoms.
What else should I know to stay safe?
- Do not use after brexpiprazole or ingredient allergy. Kidney or liver impairment, genetically slower drug processing and interacting medicines may require lower doses; the interaction rules differ for depression add-on treatment.
- Monitor weight, glucose, blood fats, blood pressure, movements, falls and compulsive urges. Previous low white-cell counts may require blood tests. Review seizures, heart disease, dehydration and swallowing difficulty; avoid alcohol, unreviewed sedatives and driving while impaired.
- Plan stopping or switching with the prescriber. Discuss pregnancy and breastfeeding because late exposure can affect newborn movement, feeding or breathing. Older adults need particular attention to falls, swallowing and overall treatment risks.
Urgent help and crisis support · Emergency & Crisis Resources (US)
What can help day to day?
- An approval for Alzheimer-related agitation does not mean Rexulti treats every dementia behavior or that the boxed warningFDA boxed warningAn FDA boxed warning is a prominently displayed warning in US prescribing information about especially serious risks, which may include death or serious injury. It is sometimes called a black-box warning.It highlights information that needs particular attention when deciding whether and how to use a medicine. A boxed warning does not mean the medicine is banned or that everyone will experience the harm. Read the medicine-specific warning and discuss it with your prescriber. disappears.
- New gambling, shopping, eating or sexual urges can be a medication effect. Patients or caregivers may need to bring it up because it is not always volunteered.
- Weight and blood-sugar monitoring remains useful even when treatment is helping mood or behavior.
How does it work?
Brexpiprazole changes how brain cells respond to dopamine and serotonin, two chemical messengers. It partly activates some receptors, the proteins that receive these messages, and blocks another type. Researchers know these actions occur, although they do not yet fully explain the medicine’s benefits in the conditions it treats.
How was this medicine developed?
The FDA first approved Rexulti in 2015 for adult schizophrenia and as an addition to antidepressants. Its later indications include adolescent schizophrenia and agitation associated with Alzheimer’s dementia. The Alzheimer-related approval did not remove the antipsychotic boxed mortality warning.
How do I say the name?
Brexpiprazole: brex-PIP-rah-zole. Capital letters show the stressed syllable.
Sources and References
Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.
- Rexulti: current sponsor prescribing information
- Rexulti: FDA approval and supplement history
- Brexpiprazole: patient medicine information
- Rexulti: FDA prescribing information
- Rexulti: Package Insert / Prescribing Information / MOA
- Vraylar: current prescribing information
- Brexpiprazole: verified neutral parent, PubChem CID 11978813
- NIMH: Understanding psychosis
- A qualitative investigation into the effects of akathisia - Health Research Authority
- Extrapyramidal side effects- Management
- Anxiety and panic attacks - NHS
- Agitation: MedlinePlus Medical Encyclopedia
- Frequently Asked Questions about Labeling for Prescription Medicines | FDA
Giving medicine safely to children: family guide (PDF, 3 pages)

